Product image of Linezolid Clonmel (Linezolid) supplied by GNH India

Linezolid Clonmel

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Clonmel (Linezolid)

Linezolid, the active ingredient in Linezolid Clonmel, is an oxazolidinone antibiotic presented as an oral formulation for systemic use. It treats infections caused by resistant Gram‑positive bacteria, including MRSA and VRE, in adult patients.
GNH India supplies Linezolid Clonmel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Clonmel Healthcare Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for infections caused by resistant Gram‑positive organisms, acting on bacterial protein synthesis pathways.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective treatment of confirmed MRSA infections.
  • Vancomycin‑resistant Enterococcus (VRE) infections: provides an alternative option for VRE infections.
  • Community‑acquired and hospital‑acquired pneumonia: improves clinical outcomes in pneumonia caused by susceptible pathogens.
  • Skin and soft‑tissue infections: resolves infections of the skin and underlying tissues caused by susceptible organisms.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible strains and bactericidal at higher concentrations, targeting Gram‑positive bacteria including resistant strains such as MRSA and VRE.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste sensation.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Anemia: reduction in red blood cell levels.
  • Peripheral neuropathy: nerve damage causing tingling or numbness.
  • Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.
  • Myelosuppression: broader suppression of bone‑marrow function.
  • Lactic acidosis: rare metabolic disturbance requiring urgent care.

Precautions & Warnings

Before initiating therapy, clinicians should consider patient‑specific factors and monitor for adverse events.

  • Renal impairment: assess renal function and monitor for accumulation.
  • Hepatic impairment: evaluate liver enzymes and adjust monitoring as needed.
  • Concomitant serotonergic drugs: avoid or closely monitor for serotonin syndrome.
  • Myelosuppression: perform regular complete blood counts during treatment.
  • Pregnancy and lactation: use only if potential benefits outweigh risks.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity.
  • Rifampicin: induces metabolism, reducing linezolid exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
  • Erythromycin: can increase linezolid plasma concentrations.
  • Antacids containing magnesium or aluminum: may affect absorption, consider timing adjustments.

Frequently Asked Questions

Linezolid Clonmel is an oral oxazolidinone antibiotic used to treat infections caused by resistant Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), certain types of pneumonia, and skin or soft‑tissue infections where the pathogen is susceptible.

Linezolid works by binding to the 23S rRNA component of the bacterial 50S ribosomal subunit. This binding prevents the formation of the initiation complex needed for protein synthesis, thereby inhibiting bacterial growth and, at higher concentrations, leading to bacterial cell death.

The specific dose of linezolid is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. Dosage regimens are individualized and should follow the prescriber's instructions.

Safety data for linezolid in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician in consultation with the patient.

To order Linezolid Clonmel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Linezolid offers oral bioavailability and activity against MRSA and VRE, which can be advantages over vancomycin, an intravenous glycopeptide. While vancomycin requires infusion and may have nephrotoxicity concerns, linezolid can be given orally but carries risks of myelosuppression and serotonin syndrome, requiring different monitoring strategies.

Linezolid Clonmel should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Linezolid Clonmel is administered orally, typically as a tablet or oral suspension, according to the prescriber's directions. The medication should be taken with or without food as advised, and the full course should be completed to ensure effective eradication of the infection.

Serious risks associated with linezolid include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome (especially when combined with serotonergic agents), and rare cases of lactic acidosis. Patients should be monitored regularly for blood‑cell abnormalities and any signs of neurological or metabolic disturbances.

Linezolid should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones. Caution is also advised for individuals taking serotonergic medications, those with existing myelosuppression, and patients with uncontrolled hypertension, as these conditions may increase the risk of adverse effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT